undamentalytics Newsletter
Sign in

Concentrix Corp (CNXC) stock

Add to watchlist

Add holding +

NASDAQ: CNXC Nasdaq Data Processing & Outsourced Services Next results ~January 13, 2027

C+ Fundamentals grade

Concentrix Corp is a US-listed company in the data processing & outsourced services industry. Its financial year ends in November.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

~$76

Cash-flow model

Base case. Range ~$40–$120 across our lower- and higher-growth cases (3.9%–13.9% a year).

Price vs value

Undervalued

The price is below our entire value range; our base value is 146% above it.

Price used: $30.89, November 2, 2026

Concentrix Corp valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders2 buying, 2 selling4 purchases and 2 sales by directors and officers, last 12 monthsInsider trades
  • Funds141 adding, 166 cuttingOf 45 active managers that changed their stake, 17 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Concentrix files

Where Concentrix stands after its latest 10-Q

Revenue for the twelve months to August 2026 was $9.97bn, up 2.6% on a year earlier, slower than the 3.9% growth a quarter earlier. Free-cash-flow margin held at 5.8%. Operating margin narrowed to -20.9% from 6.3%. The diluted share count is down 3.8% on a year earlier, which lifts each remaining share. Against its peers on growth, profitability, cash generation and balance sheet, it grades C. It passes 1 of our 6 financial-health checks. Our cash-flow model value is $75.31 a share, against a share price of $32.02. At that price, our model says the market is pricing in about 0.5% a year of cash-flow growth for five years, slower than the 12.3% a year revenue growth it has delivered.

Source: 10-Q filed October 7, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~January 13, 2027 (estimated)

Concentrix Corp's trailing-twelve-month revenue grew 2.6% year on year, with a free-cash-flow margin of 5.8%. Where it stands out: change in share count of -3.8% ranks 2 of 10 data processing & outsourced services companies we cover.

Our discounted-cash-flow model values the business at ~$76 per share in the base case (~$40–$120 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Operating margin compressing: TTM operating margin fell to -20.9%, down 27.1pp year over year.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Priced below our value. The share price of $30.89 is 146% below our value per share of $76.
  • Shrinking share count. Diluted shares fell 3.8% in a year, so each share owns more of the business.

Things to watch

  • Loss-making. Operating margin is -20.9%: costs exceed revenue.
  • Margins narrowing. Operating margin is down 27.1 points on a year ago.
  • Volatile shares. Over the past year the shares showed annualised volatility of 71% and a beta of 0.6 against the S&P 500.
  • Heavily shorted. 16.8% of the shares available to trade are sold short (4.1 days of average volume to cover).
  • Missing expectations. Earnings per share fell short of the consensus estimate in 2 of the last four quarters.

Latest results: FY2026 Q3

Filed October 7, 2026
Earnings per share
$2.92 against an average estimate of $2.70: beat by 8.1%
Revenue
$2.45bn, down 1.2% on a year earlier
Share reaction
-2.0% in the first session after the results on September 29, 2026, against -0.4% for the S&P 500
Guidance given
fourth quarter reported revenue $2.41bn to $2.46bn (Fourth Quarter Fiscal 2026); operating income $174m to $184m (Fourth Quarter Fiscal 2026)
Next report
January 13, 2027; average EPS estimate $2.92

Concentrix's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+2.5%
  • 1 week-3.5%
  • 1 month+25.4%
  • This year-21.9%
  • 1 year-19.4%
  • 5 years-81.1%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$10B
Operating margin
-20.9%
Net margin
-24.0%
EPS (TTM, diluted)
$-39.04

Growth

Revenue growth
+2.6%
Change in growth rate
−1.3 pts
Share count change
−3.8%

Cash

Free cash flow (TTM)
$575M
FCF margin
5.8%
Stock pay % of revenue
0.9%

Earnings

Last results
September 29, 2026
Next results (est.)
January 12, 2027

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Announcement
  2. Announcement
  3. Results
  4. Guidance
  5. Leadership
  6. Announcement
  7. Announcement
  8. Deal
  9. Announcement
  10. Announcement
  11. Announcement
  12. Announcement
  13. Leadership

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Concentrix Corp valuation models and calculator

What the price is pricing in

The share price implies about 0.0% a year of cash-flow growth for five years.That is slower than the 12.3% a year revenue growth Concentrix has delivered.

Read with care: free cash flow has swung sharply in the past year (often a one-off tax, legal or working-capital item), so the cash-flow base behind this reading may be unusually low or high.

  • Priced in0.0%
  • Last 12 months2.6%
  • 3 years a year15.2%
  • 5 years a year12.3%

Our cash-flow model with every input fixed except growth over the next five years, solved for the growth at which the model value equals the share price ($29.38, Nov 3, 2026). Cash-flow growth then fades to 2.5% a year; discount rate 8.5%. Delivered figures are revenue growth from SEC filings. This is a model exercise, not investment advice or a forecast of the share price. All companies

Fundamentalytics rating

model v1.6 · 2026-11-03
Buy12-month view
12-month price target
~$76
Price used
$29.38close November 3, 2026
Implied change
▲ +159%
Uncertainty
High

How we got here: a discounted-cash-flow model of Concentrix Corp's free cash flow after stock-based pay with after-tax interest added back ($400M, FY2026 Q3 TTM), growing 1.5% and 6.3% in the next two years (forecasts, guidance and its record), then back to 8.9% by year five, and fading to 2.5%, discounted at 8.5%. Lower and higher growth cases span ~$40–~$120 ; that spread sets a 35% margin before we rate Buy or Sell.

Produced by Fundamentalytics' automated valuation model on November 3, 2026, using delayed market prices. Rating meanings, methodology and conflicts: recommendations disclosure and research disclaimer. General research, not personal advice — it does not consider your circumstances. Prices can fall as well as rise.

Our value per share comes from a discounted-cash-flow model of Concentrix Corp's free cash flow after stock-based pay ( $400M, FY2026 Q3 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

Valuation models

We value Concentrix Corp as an operating company, with every model that fits that kind of business. Cost of equity 9.4%: the 10-year Treasury yield (4.9%) plus a beta of 1 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. ~$76 ~$40–$120 Primary model, counts double
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$39 ~$22–$180 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: the model gives no positive value
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: return on equity is not positive
Combined value Weighted average of the models that apply: the primary model (cash-flow model (dcf)) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$64 ~$39–$76 2 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Concentrix Corp with Data Processing & Outsourced Services in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

What moves the value

  • Revenue growth 5 points lower ▼ −43%
  • Revenue growth 5 points higher ▲ +57%
  • Free-cash-flow margin 1 point lower ▼ −30%
  • Last year's free-cash-flow margin change, if it persists ▲ +16%
  • Discount rate 1 point higher ▼ −25%
Value per share under different assumptions
Discount rate ↓ / growth → −5% growth0% growth5% growth10% growth15% growth20% growth
7% $27$61$106$165$242$342
8.5% $5$29$62$104$159$230
10% —$10$35$68$110$163

Valuation multiples over time Market data may be delayed

At fiscal year end 202020212022202320242025Now
Share price$71.15$147.83$109.77$85.32$41.65$34.43$30.89
Market value$3.7bn$7.7bn$5.7bn$4.6bn$2.7bn$2.2bn$1.9bn
+ Net debt (− = net cash)$1.0bn$623m$2.1bn$4.7bn$4.5bn$4.3bn$4.1bn
Enterprise value$4.7bn$8.3bn$7.8bn$9.3bn$7.2bn$6.5bn$6.0bn
Multiples
Price / sales 0.8x1.4x0.9x0.6x0.3x0.2x0.2x
Price / earnings 22.3x18.9x13.1x14.7x10.8x——
Price / free cash flow 10.9x21.0x12.3x9.3x6.3x3.8x3.3x
EV / EBITDA 10.7x11.6x9.9x11.2x8.6x——

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

29 /100

Weak moat

How hard Concentrix's competitive advantage looks for rivals to wear away, judged from 6 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 7 / 20

    Cash operating profit has been a median 6.3% of total assets over 5 years.

  • Pricing power 13 / 20

    Gross margin has been a median 35.4%, moving by 0.7 percentage points (standard deviation) across 6 years.

  • Durability 1 / 20

    Operating margin has been a median 8.3%; its worst year was -20.9%.

  • Cash conversion 13 / 20

    Free cash flow was positive in 6 of 6 years, at a median 5.5% of revenue.

  • Discipline 11 / 20

    The diluted share count rose 18.1% over five years; stock-based pay has been a median 0.9% of revenue.

AI disruption exposure: High. In this industry, the core product is information work that AI systems increasingly perform. The score above includes a 15-point deduction for that exposure (44 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: January 13, 2027, after the close. Analysts expect revenue of $2.4bn and EPS of $2.92 (range $2.90 to $2.94) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $11.05 −2% $9.9bn +0%
Next $11.52 +4% $9.8bn −0%

Next year's EPS estimate has moved −3.1% in 90 days, across 5 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −1.3% on 90 days ago. In the last 30 days, 3 analysts raised Concentrix Corp's forecast and 0 cut it.

Consensus EPS forecast Concentrix Corp, last 90 days
$10.50 $11.00 $11.50 $12.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $11.20 Current fiscal year, 60 days ago: $11.20 Current fiscal year, 30 days ago: $10.97 Current fiscal year, 7 days ago: $11.05 Current fiscal year, Now: $11.05 $11.05 Next fiscal year, 90 days ago: $11.89 Next fiscal year, 60 days ago: $11.89 Next fiscal year, 30 days ago: $11.57 Next fiscal year, 7 days ago: $11.52 Next fiscal year, Now: $11.52 $11.52

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $11.20$11.89
60 days ago $11.20$11.89
30 days ago $10.97$11.57
7 days ago $11.05$11.52
Now $11.05$11.52

Earnings against estimates

Quarter toEstimateActualSurprise
Aug 2026 $2.70 $2.92 +8.1%
May 2026 $2.64 $2.63 −0.3%
Feb 2026 $2.65 $2.61 −1.3%
Nov 2025 $2.91 $2.95 +1.4%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, September 29, 2026
  • Full year reported revenue Full Year 2026 $9.827bn to $9.877bn GAAP
    “Full year reported revenue of $9.827 billion to $9.877 billion.” source
  • Fourth quarter reported revenue Fourth Quarter Fiscal 2026 $2.41bn to $2.46bn GAAP
    “Fourth quarter reported revenue of $2.410 billion to $2.460 billion.” source
  • Non-GAAP diluted EPS Full Year 2026 $10.97 to $11.09 Non-GAAP
    “Non-GAAP diluted EPS of $10.97 to $11.09, assuming approximately 61.1 million diluted common shares outstanding and approximately 4.9% of net income attributable to participating securities.” source
  • Non-GAAP diluted EPS Fourth Quarter Fiscal 2026 $2.86 to $2.98 Non-GAAP
    “Non-GAAP diluted EPS of $2.86 to $2.98, assuming approximately 61.2 million diluted common shares outstanding and approximately 4.9% of net income attributable to participating securities.” source
  • Operating loss Full Year 2026 $-522m to $-512m GAAP
    “Operating loss of $(522) million to $(512) million and non-GAAP operating income of $1,206 million to $1,216 million.” source
  • Non-GAAP operating income Full Year 2026 $1,206m to $1,216m Non-GAAP
    “Operating loss of $(522) million to $(512) million and non-GAAP operating income of $1,206 million to $1,216 million.” source
Show 5 more items
  • Effective tax rate Full Year 2026 about 24%
    “The effective tax rate is expected to be approximately 24%.” source
  • Adjusted free cash flow fiscal year 2026 $630m to $650m Non-GAAP
    “In addition, the Company expects to generate approximately $630.0 million to $650.0 million of adjusted free cash flow in fiscal year 2026.” source
  • Operating income Fourth Quarter Fiscal 2026 $174m to $184m GAAP
    “Operating income of $174 million to $184 million and non-GAAP operating income of $310 million to $320 million.” source
  • Non-GAAP operating income Fourth Quarter Fiscal 2026 $310m to $320m Non-GAAP
    “Operating income of $174 million to $184 million and non-GAAP operating income of $310 million to $320 million.” source
  • Effective tax rate Fourth Quarter Fiscal 2026 about 24%
    “The effective tax rate is expected to be approximately 24%.” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

How our valuation uses these forecasts

Our cash-flow model grows Concentrix Corp's revenue by +1.5% next year and +6.3% the year after, then fades back toward its own record by year five. Next year's rate weighs analysts' consensus (-1.4%, weight 51%) , management guidance (-1.4%, weight 21%) and the company's own record (+8.9%, weight 28%) . How the weights are set.

Analyst recommendations

5 analysts, Nov 2026
Buy360%
Hold240%
Sell00%

Monthly trend

  1. Nov 20261225
  2. Oct 20261214

Counts of recommendations published by analysts covering Concentrix Corp, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
16.8%
of tradable shares
Days to cover
4.07
at average volume
Short interest, 1 month
+1%
to October 15, 2026
Held by institutions
—
of shares
Held by insiders
15.6%
of shares
Employees
455,000
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months −19.4%

$38.33 on October 31, 2025 to $30.89

ThenNowEffect
Revenue (last 12 months) $9.7bn $10.0bn +2.6%
P/S multiple 0.3x 0.2x −24.4%
Share count 64m 61m +3.9%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

Last 3 years −58.2%

$73.86 on November 3, 2023 to $30.89

ThenNowEffect
Revenue (last 12 months) $6.5bn $10.0bn +52.8%
P/S multiple 0.6x 0.2x −67.4%
Share count 51m 61m −16.1%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
CNXC+81%−25%−25%−55%−1%−22%
Industry peers (median)+6%−25%+2%−8%−29%−29%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
CNXC83%33%42%42%42%46%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
CNXC−13%−47%−53%−64%−49%−51%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 24, 2020: 89% from February 9, 2022 to July 9, 2026. Getting back needed a 800% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$20.40 – $41.91
From 52-week high
−26.3%
vs 50-day average
+9.1%
vs 200-day average
+11.6%
Volatility (1 year)
71%
Beta vs S&P 500
0.61

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
5 up, 7 down
typical move ±12.8%
After a week
5 up, 7 down
typical move ±11.5%
After a month
6 up, 6 down
typical move ±15.8%
Results releasedNext dayS&P 500 next day5 days21 days
September 29, 2026 −2.0% −0.4% −2.4% +21.3%
June 29, 2026 −10.4% +2.4% −8.6% +8.0%
March 24, 2026 −25.3% +0.2% −17.2% −19.0%
January 13, 2026 +2.3% −0.7% +3.1% −24.6%
September 25, 2025 −14.3% +0.1% −14.0% −15.0%
June 26, 2025 −4.5% +1.3% +5.5% +11.0%
March 26, 2025 +44.0% −1.5% +20.0% +11.9%
January 15, 2025 +4.9% +1.6% +12.8% +4.2%
September 25, 2024 −19.3% +0.2% −19.0% −28.3%
June 26, 2024 +6.7% +0.3% +12.2% +15.2%
March 26, 2024 +4.1% +0.7% −8.2% −10.9%
January 24, 2024 −16.4% +0.7% −14.9% −20.4%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Options strategies

All options ideas

How Concentrix Corp’s listed options are priced, and three ways to use them that follow from our valuation. Quotes are delayed, read November 2, 2026. Check the live chain at your broker before trading.

Implied vs realised volatility

Options look cheap

Option prices imply less movement than the shares have recently shown. Selling options pays little for the risk taken.

  • Implied is 0.95× the last 60 days’ realised volatility , richer than 14% of the 229 stocks we screen today.
  • Calls are priced 3 points richer than puts (25-delta): demand for upside is high, which favours selling calls over puts.
  • Why: implied is below 60-day realised: selling options pays little for the risk taken.

Our rule for “rich”: implied at least 1.2× 60-day realised (beyond measurement noise), above 1-year realised (not just a calm spell), and in the top 20% of our coverage that day. Never with results inside the option’s life. These are our conventions, built on research showing option prices usually imply more movement than follows, most when the gap is wide. How we judge this.

Cash-secured put

Not offered: fundamentals grade C+ (needs B+ or better).

We suggest selling a put only on well-rated companies, at a strike where the price you would pay if assigned (strike less premium) is at or below our fair value.

Covered call

Not offered: no liquid call at or above our price target — the model says the upside is worth more than any listed strike.

For holders: sell a call at a strike at or above our fair value, so the shares are only sold at a price the model calls full value.

Collar

Not offered: the shares trade below our fair value: a collar caps upside the model expects.

For holders of a stock trading at or above our fair value: buy a put for a floor and sell a call to pay for it.

General research, not personal advice. Options can lose you more than you expect and are not suitable for everyone: put sellers can be made to buy shares that keep falling, call sellers give up gains above the strike, and results or news can move prices sharply. Chances shown are approximations from each option’s delta. Spreads, fees and early assignment are not modelled.

Concentrix Corp in five measures

Fundamentals grade C+
Growth Profitability Cash Balance sheet Value

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Concentrix Corp
$7B $8B $9B $10B FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue (TTM), FY23 Q4: $7.1B Revenue (TTM), FY24 Q1: $7.9B Revenue (TTM), FY24 Q2: $8.6B Revenue (TTM), FY24 Q3: $9.4B Revenue (TTM), FY24 Q4: $9.6B Revenue (TTM), FY25 Q1: $9.6B Revenue (TTM), FY25 Q2: $9.6B Revenue (TTM), FY25 Q3: $9.7B Revenue (TTM), FY25 Q4: $9.8B Revenue (TTM), FY26 Q1: $10B Revenue (TTM), FY26 Q2: $10B Revenue (TTM), FY26 Q3: $10B $10B

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Revenue (TTM)
FY23 Q4 $7.1B
FY24 Q1 $7.9B
FY24 Q2 $8.6B
FY24 Q3 $9.4B
FY24 Q4 $9.6B
FY25 Q1 $9.6B
FY25 Q2 $9.6B
FY25 Q3 $9.7B
FY25 Q4 $9.8B
FY26 Q1 $10B
FY26 Q2 $10B
FY26 Q3 $10B
Revenue growth, TTM YoY Concentrix Corp
0% 20% 40% 60% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue growth, TTM YoY, FY23 Q4: 12.5% Revenue growth, TTM YoY, FY24 Q1: 22.7% Revenue growth, TTM YoY, FY24 Q2: 33.6% Revenue growth, TTM YoY, FY24 Q3: 44.1% Revenue growth, TTM YoY, FY24 Q4: 35.2% Revenue growth, TTM YoY, FY25 Q1: 21.7% Revenue growth, TTM YoY, FY25 Q2: 11.3% Revenue growth, TTM YoY, FY25 Q3: 3.4% Revenue growth, TTM YoY, FY25 Q4: 2.2% Revenue growth, TTM YoY, FY26 Q1: 3.8% Revenue growth, TTM YoY, FY26 Q2: 3.9% Revenue growth, TTM YoY, FY26 Q3: 2.6% 2.6%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q4 12.5%
FY24 Q1 22.7%
FY24 Q2 33.6%
FY24 Q3 44.1%
FY24 Q4 35.2%
FY25 Q1 21.7%
FY25 Q2 11.3%
FY25 Q3 3.4%
FY25 Q4 2.2%
FY26 Q1 3.8%
FY26 Q2 3.9%
FY26 Q3 2.6%
Operating margin (TTM) Concentrix Corp
-30% -20% -10% 0% 10% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Operating margin (TTM), FY23 Q4: 9.3% Operating margin (TTM), FY24 Q1: 8.3% Operating margin (TTM), FY24 Q2: 7.4% Operating margin (TTM), FY24 Q3: 6.7% Operating margin (TTM), FY24 Q4: 6.2% Operating margin (TTM), FY25 Q1: 6.4% Operating margin (TTM), FY25 Q2: 6.4% Operating margin (TTM), FY25 Q3: 6.3% Operating margin (TTM), FY25 Q4: -9.3% Operating margin (TTM), FY26 Q1: -9.7% Operating margin (TTM), FY26 Q2: -10.2% Operating margin (TTM), FY26 Q3: -20.9% -20.9%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q4 9.3%
FY24 Q1 8.3%
FY24 Q2 7.4%
FY24 Q3 6.7%
FY24 Q4 6.2%
FY25 Q1 6.4%
FY25 Q2 6.4%
FY25 Q3 6.3%
FY25 Q4 -9.3%
FY26 Q1 -9.7%
FY26 Q2 -10.2%
FY26 Q3 -20.9%
FCF margin (TTM) Concentrix Corp
3% 4% 5% 6% 7% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 FCF margin (TTM), FY23 Q4: 7.0% FCF margin (TTM), FY24 Q1: 4.2% FCF margin (TTM), FY24 Q2: 4.7% FCF margin (TTM), FY24 Q3: 3.9% FCF margin (TTM), FY24 Q4: 4.5% FCF margin (TTM), FY25 Q1: 5.0% FCF margin (TTM), FY25 Q2: 5.0% FCF margin (TTM), FY25 Q3: 5.3% FCF margin (TTM), FY25 Q4: 5.8% FCF margin (TTM), FY26 Q1: 4.9% FCF margin (TTM), FY26 Q2: 5.1% FCF margin (TTM), FY26 Q3: 5.8% 5.8%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q4 7.0%
FY24 Q1 4.2%
FY24 Q2 4.7%
FY24 Q3 3.9%
FY24 Q4 4.5%
FY25 Q1 5.0%
FY25 Q2 5.0%
FY25 Q3 5.3%
FY25 Q4 5.8%
FY26 Q1 4.9%
FY26 Q2 5.1%
FY26 Q3 5.8%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2019 Nov 2019 2020 Nov 2020 2021 Nov 2021 2022 Nov 2022 2023 Nov 2023 2024 Nov 2024 2025 Nov 2025 LTM Aug 2026
Income
Revenue 4,708 4,720 5,587 6,324 7,115 9,619 9,826 9,969
Gross profit 1,748 1,662 1,969 2,257 2,578 3,449 3,435 3,398
EBITDA 434 438 713 787 835 843 −692 −1,850
Operating income 294 309 572 640 661 596 −918 −2,079
Net income 117 165 406 435 314 251 −1,279 −2,391
Diluted EPS $2.27 $3.19 $7.70 $8.28 $5.70 $3.71 −$20.36 −$39.04
Growth (year on year)
Revenue — +0.2% +18.4% +13.2% +12.5% +35.2% +2.2% +2.6%
EBITDA — +1.0% +62.7% +10.4% +6.1% +1.0% −182.1% −321.5%
Operating income — +4.9% +85.4% +11.8% +3.3% −9.8% −254.0% −441.5%
Net income — +40.7% +146.1% +7.3% −27.9% −20.0% −609.1% −856.3%
Diluted EPS — +40.5% +141.4% +7.5% −31.2% −34.9% −648.8% −886.1%
Margins
Gross margin 37.1% 35.2% 35.3% 35.7% 36.2% 35.9% 35.0% 34.1%
EBITDA margin 9.2% 9.3% 12.8% 12.4% 11.7% 8.8% −7.0% −18.6%
Operating margin 6.3% 6.5% 10.2% 10.1% 9.3% 6.2% −9.3% −20.9%
Net margin 2.5% 3.5% 7.3% 6.9% 4.4% 2.6% −13.0% −24.0%
Free-cash-flow margin 7.2% 7.1% 6.5% 7.3% 7.0% 4.5% 5.8% 5.8%
Cash flow
Cash from operations 450 508 514 601 678 667 807 787
Capital spending 111 171 149 140 181 239 234 212
Free cash flow 339 336 365 461 497 429 572 575
Stock-based pay 10 16 36 47 62 96 96 93
Free cash flow after stock pay 328 321 329 414 435 333 476 482
Balance sheet
Cash 84 153 182 145 295 241 327 245
Total debt 0 1,179 805 2,232 4,998 4,768 4,653 4,375
Net debt (negative = net cash) −84 1,026 623 2,086 4,703 4,527 4,325 4,131
Diluted shares 52m 52m 52m 52m 54m 65m 63m 61m
Returned to shareholders
Dividends 0 0 13 53 63 84 90 92
Buybacks 0 0 25 121 64 136 169 99
Total returned 0 0 38 174 127 220 258 192

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

1 of 6 checks passed · August 31, 2026
What it owns · $9.3bn
Short-term assets $2.9bnLonger-term assets $6.3bn
What it owes, and who funded it · $9.3bn
Short-term liabilities $2.4bnLonger-term liabilities $5.1bnShareholders' equity $1.8bn
  • Short-term assets cover short-term liabilities $2.9bn of assets due within a year against $2.4bn of liabilities due within a year.
  • Short-term assets cover long-term liabilities $2.9bn short-term assets against $5.1bn of longer-dated liabilities.
  • More cash than debt $245m of cash against $4.4bn of debt.
  • Debt below 40% of shareholders' equity Debt is 247% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 83% to 247% over five years.
  • A year's operating cash flow covers at least 20% of debt $787m of operating cash flow against $4.4bn of debt.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Concentrix Corp's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

FY2026 Q3 TTM
Buybacks (TTM)
$99.1M
Dividends (TTM)
$92.5M
Returned to shareholders
33%
of free cash flow
Buybacks, last 3 fiscal years
$369M
Diluted share count
−3.8%
year over year
Total shareholder yield
10.2%
dividends 4.9% + buybacks 5.3% of market value
Sales & admin spending
29.1%
of revenue
Days sales outstanding
72 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in data processing & outsourced services
Last 12 months unless stated CNXC BR MMS ALIT TTEC TASK Median
Revenue, last 12 months $10.0bn $7.5bn $5.2bn $2.2bn $2.0bn $1.2bn $1.2bn
Revenue growth, last 12 months 2.6% 8.5% −3.3% −3.5% −4.8% 11.4% 6.3%
Revenue growth, 3-year average 15.2% 7.2% 2.9% 5.2% −6.3% 9.3% 7.2%
Revenue growth, latest quarter −1.2% 7.5% −5.1% −3.2% −11.3% 5.0% 5.0%
Gross margin 34.1% 31.8% 25.6% 32.1% — — 33.1%
Operating margin −20.9% 17.4% 11.0% −95.7% −6.4% 11.7% −1.6%
Operating margin, 3-year average −2.6% 16.8% 9.9% −47.9% −3.3% 10.9% −3.0%
Net margin −24.0% 15.0% 7.1% −90.9% −10.2% 8.8% −7.9%
Cash from operations / revenue 7.9% 18.0% 8.9% 15.8% 4.2% 14.1% 10.9%
Free-cash-flow margin 5.8% 17.1% 8.3% 11.2% 2.0% 9.8% 8.3%
Free-cash-flow margin, 3-year average 5.0% 16.3% 4.3% 9.4% 0.1% 9.0% 5.7%
Stock pay / revenue 0.9% 1.3% 0.7% 0.9% 0.6% 1.9% 1.3%
Change in share count −3.8% −1.0% −6.3% 0.0% 1.3% −0.1% −0.0%

Median of all 11 companies we cover in data processing & outsourced services. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

11 data processing & outsourced services companies
Measure Company Peer median Rank
Revenue growth Growth 2.6% 6.3% 7 of 11
Change in growth rate Growth -1.3pp -1.3pp 5 of 11
Gross margin Profitability 34.1% 34.1% 3 of 6
Operating margin Profitability -20.9% 3.3% 8 of 10
Net margin Profitability -24.0% -7.9% 8 of 11
Free-cash-flow margin Cash generation 5.8% 8.3% 7 of 11
Stock pay as % of revenue Cash generation 0.9% 1.9% 4 of 10
Long-term debt as % of assets Balance sheet 42.4% 42.4% 4 of 7
Change in share count Balance sheet -3.8% 0.0% 2 of 10
Days sales outstanding Balance sheet 72 days 71 days 6 of 9

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to November 30, 2025
Geography
Region Revenue Share YoY
OTHERS $5.1B 51.5% ▲ 6.2%
PH $1.6B 16.2% ▼ 0.1%
United States $1.1B 11.5% ▲ 6.8%
India $1.1B 10.7% ▼ 5.3%
United Kingdom $356M 3.6% ▼ 9.7%
Germany $334M 3.4% ▼ 13.8%
Canada $302M 3.1% ▼ 1.8%

From Concentrix Corp's 10-K filed January 28, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$1.5B
Institutions reporting
267
Shares held vs prior quarter
▲ 0.5%
Positions opened / closed
44 / 76

Top buyers and sellers, Q2 2026: 141 institutions bought and 166 sold ; the biggest buyer was Blackrock, Inc (+2.6M shares) and the biggest seller Groupe Bruxelles Lambert (−6.0M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $150M 6.7M 9.8% ▲ 64.4%
FMR LLC $128M 5.7M 8.4% ▲ 35.3%
Pzena Investment Management LLC $76.5M 3.4M 5.0% ▲ 16.0%
Kopernik Global Investors, LLC $71.2M 3.2M 4.7% ▲ 95.2%
UBS Group AG $71M 3.2M 4.7% ▲ 38.5%
AQR Capital Management LLC $65.3M 3.3M 4.3% ▼ 32.3%
Vanguard Portfolio Management LLC $64M 2.9M 4.2% ▲ 20.5%
Groupe Bruxelles Lambert $62.2M 2.8M 4.1% ▼ 68.4%
Dimensional Fund Advisors LP $58.9M 2.6M 3.9% ▼ 10.9%
Fil Ltd $54.6M 2.4M 3.6% ▲ 0.3%
Vanguard Capital Management LLC $50M 2.2M 3.3% ▲ 1.7%
1832 Asset Management L.P. $48.1M 2.1M 3.2% ▼ 0.1%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Concentrix Corp's complete shareholder register. Values are as reported by the filers ; 2 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $155,165 4 trades by 2 insiders, last 12 months Insider sales History → $134M 2 trades by 2 insiders · 0% under pre-set plans
Net ▼ $133M net selling
Insider Date Trade Shares Price Value
Caldwell Christopher A President and CEO July 8, 2026 Buy 1,000 $21.25 $21,250
Gbl Verwaltung S.A. 10% owner April 29, 2026 Sell 6,000,000 $22.25 $134M
Valentine Andre S Chief Financial Officer April 9, 2026 Buy 2,500 $27.95 $69,875
Caldwell Christopher A President and CEO March 26, 2026 Buy 1,000 $26.97 $26,970
Caldwell Christopher A President and CEO January 29, 2026 Buy 1,000 $37.07 $37,070
Twomey Cormac J EVP, Global Ops & Delivery November 28, 2025 Sell pre-set plan 500 $35.50 $17,750

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around January 12, 2027 estimated from the company's past filing pattern, not announced

  • September 29, 2026
  • June 29, 2026
  • March 24, 2026
  • January 13, 2026
  • September 25, 2025
  • June 26, 2025

Recent SEC filings

Data status

When each part of this page on Concentrix Corp was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Concentrix Corp in brief

What does Concentrix Corp do?
Concentrix Corp is a US-listed company in the data processing & outsourced services industry. Its financial year ends in November.
What is Concentrix Corp's stock ticker?
Concentrix Corp trades under the ticker CNXC on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Concentrix Corp's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Concentrix Corp reported revenue of $10B, 2.6% higher than a year earlier, according to its SEC filings.
What is Concentrix Corp's free cash flow?
Concentrix Corp's free-cash-flow margin is 5.8% of revenue over the trailing twelve months, ranking 7 of the 11 data processing & outsourced services companies we cover.
What is Concentrix Corp's fair value (intrinsic value) per share?
Our discounted-cash-flow model of Concentrix Corp's free cash flow after stock-based pay gives ~$76 per share in the base case, and ~$40–$120 across growth scenarios. These are model values under stated assumptions — not a price target or a recommendation.
Who are Concentrix Corp's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., FMR LLC and Pzena Investment Management LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is Concentrix Corp buying back stock, and does it pay a dividend?
Concentrix Corp spent $99.1M on share repurchases over the trailing twelve months, and its diluted share count fell 3.8% over the year.
What is Concentrix Corp's market cap?
On November 2, 2026, Concentrix Corp's market capitalisation was about $1.9B and net debt of $4.1B. Market figures come from third-party market data and may be delayed.
Does Concentrix Corp pay a dividend?
Yes: Concentrix Corp paid $92.5M in dividends over the trailing twelve months, a dividend yield of 4.91%.
How much debt does Concentrix Corp have?
Concentrix Corp's debt-to-equity ratio is 247.4%, from its latest balance sheet (83.0% five years earlier). The financial health section below sets out its other solvency checks.
Who are Concentrix Corp's competitors?
In our Data Processing & Outsourced Services peer group, the companies closest to Concentrix Corp are Broadridge Financial Solutions, Maximus, Inc., Alight, Inc. / Delaware, Ttec Holdings, Inc. and Taskus, Inc. The side-by-side comparison below sets their revenue, margins and growth against Concentrix Corp's.
Are insiders buying or selling Concentrix Corp stock?
Over the last 12 months, Concentrix Corp's directors and officers reported 4 open-market purchases and 2 sales on Form 4. The insider trading page charts every trade.
When is Concentrix Corp's next earnings date?
Around January 13, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Concentrix Corp announces its own schedule.